Gilead Sciences Inc
MIL:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
MIL:GILD
|
US |
|
I
|
Integra Lifesciences Holdings Corp
XMUN:IL3
|
US |
Wall St Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GILD is 85.93 EUR with a low forecast of 65.64 EUR and a high forecast of 100.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GILD's stock price target?
Price Target
85.93
EUR
According to Wall Street analysts, the average 1-year price target for GILD is 85.93 EUR with a low forecast of 65.64 EUR and a high forecast of 100.68 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
